SGLT2i to Prevent of Liver Complications in Patients With CHB and Diabetes Mellitus
Conditions: Chronic Hepatitis B Interventions: Drug: Dapagliflozin 10mg Tab; Drug: Placebo 10mg Tab Sponsors: Chinese University of Hong Kong Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: China Health | Dapagliflozin | Diabetes | Diabetes Mellitus | Endocrinology | Forxiga | Hepatitis | Hepatitis B | Hong Kong Health | Liver | Research | Urology & Nephrology